Article
Functional analysis of the p57KIP2 gene mutation in Beckwith-Wiedemann syndrome.
Human genetics - 1 Mar 1999
Bhuiyan Z A, Yatsuki H, Sasaguri T, Joh K, Soejima H, Zhu X, Hatada I, Morisaki H, Morisaki T, Mukai T
Abstract excerpt
p57KIP2 is a potent tight-binding inhibitor of several G1 cyclin/cyclin-dependent kinase (Cdk) complexes, and is a negative regulator of cell proliferation. The gene encoding p57KIP2 is located at 11p15.5, a region implicated in both sporadic cancers and Beckwith-Wiedemann syndrome (BWS). Previously we demonstrated that p57KIP2 is imprinted and only the maternal allele is expressed in both mice and humans. We...
Topics
- Animals
- Beckwith-Wiedemann Syndrome
- CDC2-CDC28 Kinases
- COS Cells
- Cell Nucleus
- Cyclin-Dependent Kinase 2
- Cyclin-Dependent Kinase Inhibitor p57
- Cyclin-Dependent Kinases
- Escherichia coli
- Fluorescent Antibody Technique
